CTHM
MCID: CNT061
MIFTS: 64

Conotruncal Heart Malformations (CTHM)

Categories: Cardiovascular diseases, Fetal diseases, Genetic diseases, Rare diseases

Aliases & Classifications for Conotruncal Heart Malformations

MalaCards integrated aliases for Conotruncal Heart Malformations:

Name: Conotruncal Heart Malformations 57 53 59 74 29 6 72
Persistent Truncus Arteriosus 57 75 53 74 37 6
Conotruncal Anomaly Face Syndrome 57 74 72
Common Arterial Trunk 59 74 33
Truncus Arteriosus 59 29 6
Cthm 57 53 74
Double-Outlet Right Ventricle 74 37
Truncus Arteriosus Communis 74 29
Dorv 59 74
Tac 59 74
Conotruncal Heart Malformations, Variable 57
Heart Malformations,conotruncal 40
Truncus Arteriosus, Persistent 44
Double Outlet Right Ventricle 59
Common Aorticopulmonary Trunk 59
Conotruncal Cardiac Defects 53
Conotruncal Heart Defects 74
Cafs 74
Cthd 74
Pta 74

Characteristics:

Orphanet epidemiological data:

59
truncus arteriosus
Inheritance: Autosomal recessive,Not applicable; Prevalence: 1-9/100000 (Worldwide),1-9/100000 (Europe),1-9/100000 (Belgium),1-9/100000 (France),1-9/100000 (Germany),1-9/100000 (Hungary),1-9/100000 (Ireland),1-9/100000 (Italy),1-9/100000 (Netherlands),1-9/100000 (Norway),1-9/100000 (Poland),1-9/100000 (Spain),1-5/10000 (Switzerland),1-9/100000 (United Kingdom),1-9/100000 (Ukraine); Age of onset: Infancy,Neonatal;
double outlet right ventricle
Inheritance: Multigenic/multifactorial; Prevalence: 1-5/10000 (Germany); Age of onset: Infancy,Neonatal; Age of death: normal life expectancy;

HPO:

32
conotruncal heart malformations:
Inheritance autosomal recessive inheritance


Classifications:



External Ids:

OMIM 57 217095
ICD10 33 Q20.0
MESH via Orphanet 45 D004310
ICD10 via Orphanet 34 Q20.0 Q20.1
UMLS via Orphanet 73 C0013069 C0041207 C1857586
UMLS 72 C0795907 C1857586

Summaries for Conotruncal Heart Malformations

NIH Rare Diseases : 53 The following summary is from Orphanet, a European reference portal for information on rare diseases and orphan drugs.Orpha Number: 2445DefinitionA group of congenital cardiac outflow tract anomalies that include such defects as tetralogy of Fallot, pulmonary atresia with ventricular septal defect, double-outlet right ventricle (DORV), double-outlet left ventricle, truncus arteriosus and transposition of the great arteries (TGA), among others. This group of defects is frequently found in patients with 22q11.2 deletion syndrome . A deletion of chromosome 22q11.2 has equally been associated in a subset of patients with various types of isolated non-syndromic conotruncal heart malformations (with the exception of DORV and TGA where this is very uncommon).Visit the Orphanet disease page for more resources.

MalaCards based summary : Conotruncal Heart Malformations, also known as persistent truncus arteriosus, is related to velocardiofacial syndrome and esophageal atresia/tracheoesophageal fistula. An important gene associated with Conotruncal Heart Malformations is NKX2-6 (NK2 Homeobox 6), and among its related pathways/superpathways is Heart Development. The drugs Simendan and Cardiotonic Agents have been mentioned in the context of this disorder. Affiliated tissues include Heart and Heart, and related phenotypes are tetralogy of fallot and transposition of the great arteries

KEGG : 37
Double outlet right ventricle (DORV) is a clinically significant congenital heart defect. DORV is a condition in which the aorta rises from the right ventricle and is associated with ventricular septal defect. Chromosomal abnormalities are present in some cases of DORV. Trisomies 13 and 18, and del 22q11 are the most commonly associated cytogenetic lesions. Mutations in the CFC1 and GDF1 genes were the most commonly reported monogenic loci associated with DORV in humans.

UniProtKB/Swiss-Prot : 74 Conotruncal heart malformations: A group of congenital heart defects involving the outflow tracts. Examples include truncus arteriosus communis, double-outlet right ventricle and transposition of great arteries. Truncus arteriosus communis is characterized by a single outflow tract instead of a separate aorta and pulmonary artery. In transposition of the great arteries, the aorta arises from the right ventricle and the pulmonary artery from the left ventricle. In double outlet of the right ventricle, both the pulmonary artery and aorta arise from the right ventricle.

Wikipedia : 75 Persistent truncus arteriosus is a rare form of congenital heart disease that presents at birth. In this... more...

More information from OMIM: 217095

Related Diseases for Conotruncal Heart Malformations

Diseases related to Conotruncal Heart Malformations via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 595)
# Related Disease Score Top Affiliating Genes
1 velocardiofacial syndrome 32.6 TBX1 NKX2-6
2 esophageal atresia/tracheoesophageal fistula 30.5 TBX1 NKX2-6
3 visceral heterotaxy 30.3 NKX2-6 GDF1
4 diaphragmatic hernia, congenital 30.2 ZFPM2 GATA6
5 tricuspid atresia 30.2 ZFPM2 NKX2-6 GDF1
6 hypoplastic left heart syndrome 30.2 NKX2-6 NKX2-5
7 transposition of the great arteries 29.9 NKX2-5 GDF1
8 patent foramen ovale 29.7 NKX2-6 NKX2-5 GATA6
9 holt-oram syndrome 29.7 TBX1 NKX2-5
10 aortic valve disease 1 29.1 NKX2-6 NKX2-5
11 atrioventricular septal defect 28.9 TBX1 NKX2-6 NKX2-5 GDF1 GATA6
12 atrial heart septal defect 28.9 NKX2-6 NKX2-5 GDF1 GATA6
13 ventricular septal defect 28.8 ZFPM2 NKX2-6 NKX2-5 GDF1 GATA6
14 patent ductus arteriosus 1 28.7 NKX2-6 NKX2-5 GDF1 GATA6
15 heart septal defect 28.3 ZFPM2 TBX1 NKX2-6 NKX2-5 GDF1 GATA6
16 heart disease 28.2 TBX1 NKX2-6 NKX2-5 GDF1 GATA6
17 tetralogy of fallot 27.7 ZFPM2 TBX1 NKX2-6 NKX2-5 GDF1 GATA6
18 double outlet right ventricle 27.3 ZFPM2 TBX1 NKX2-6 NKX2-5 GDF1 GATA6
19 double outlet right ventricle with subaortic or doubly committed ventricular septal defect with pulmonary stenosis 13.0
20 double outlet right ventricle with subaortic or doubly committed ventricular septal defect 12.8
21 double outlet right ventricle with non-committed subpulmonary ventricular septal defect 12.8
22 double outlet right ventricle with atrioventricular septal defect, pulmonary stenosis, heterotaxy 12.7
23 sacral meningocele conotruncal heart defects 12.6
24 beemer ertbruggen syndrome 12.0
25 factor xi deficiency 11.9
26 microphthalmia microtia fetal akinesia 11.8
27 genitopalatocardiac syndrome 11.8
28 spondylocostal dysostosis 5 11.7
29 ritscher-schinzel syndrome 1 11.7
30 congenital heart defects, multiple types, 6 11.7
31 aortopulmonary window 11.6
32 cluster headache 11.6
33 cardiac, facial, and digital anomalies with developmental delay 11.6
34 vertebral anomalies and variable endocrine and t-cell dysfunction 11.6
35 critical congenital heart disease 11.6
36 sunct headache 11.4
37 takayasu arteritis 11.4
38 heart defects, congenital, and other congenital anomalies 11.4
39 structural heart defects and renal anomalies syndrome 11.4
40 verloove vanhorick brubakk syndrome 11.4
41 isotretinoin embryopathy-like syndrome 11.3
42 emanuel syndrome 11.3
43 dextrocardia 10.7
44 pulmonic stenosis 10.7
45 subvalvular aortic stenosis 10.7
46 aortic arch interruption 10.7
47 situs inversus 10.6
48 t-cell leukemia 10.6
49 leukemia, t-cell, chronic 10.6
50 heterotaxy 10.6

Graphical network of the top 20 diseases related to Conotruncal Heart Malformations:



Diseases related to Conotruncal Heart Malformations

Symptoms & Phenotypes for Conotruncal Heart Malformations

Human phenotypes related to Conotruncal Heart Malformations:

59 32 (show all 38)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 tetralogy of fallot 59 32 hallmark (90%) Very frequent (99-80%),Occasional (29-5%) HP:0001636
2 transposition of the great arteries 59 32 hallmark (90%) Very frequent (99-80%) HP:0001669
3 patent ductus arteriosus 59 32 frequent (33%) Frequent (79-30%) HP:0001643
4 pulmonary artery atresia 59 32 frequent (33%) Frequent (79-30%),Occasional (29-5%) HP:0004935
5 abnormal aortic arch morphology 32 frequent (33%) HP:0012303
6 hypertelorism 59 32 occasional (7.5%) Frequent (79-30%) HP:0000316
7 coarctation of aorta 59 32 Occasional (29-5%) HP:0001680
8 truncus arteriosus 59 32 Occasional (29-5%) HP:0001660
9 double outlet right ventricle 59 32 Obligate (100%) HP:0001719
10 failure to thrive 59 Frequent (79-30%)
11 depressed nasal bridge 59 Frequent (79-30%)
12 short stature 59 Frequent (79-30%)
13 intellectual disability, mild 59 Frequent (79-30%)
14 abnormality of metabolism/homeostasis 32 HP:0001939
15 cleft palate 59 Frequent (79-30%)
16 feeding difficulties 59 Frequent (79-30%)
17 narrow mouth 59 Frequent (79-30%)
18 hypoplastic left heart 59 Frequent (79-30%)
19 hypoparathyroidism 59 Occasional (29-5%)
20 aplasia/hypoplasia of the thymus 59 Occasional (29-5%)
21 ventricular septal defect 59 Frequent (79-30%)
22 intestinal malrotation 59 Occasional (29-5%)
23 hypocalcemia 59 Occasional (29-5%)
24 abnormality of the aortic arch 59 Frequent (79-30%)
25 pulmonic stenosis 59 Frequent (79-30%)
26 abnormality of the pulmonary artery 59 Frequent (79-30%)
27 abnormal aortic morphology 59 Frequent (79-30%)
28 tachycardia 59 Frequent (79-30%)
29 submucous cleft hard palate 59 Frequent (79-30%)
30 tachypnea 59 Frequent (79-30%)
31 cyanosis 59 Very frequent (99-80%)
32 heart murmur 59 Frequent (79-30%)
33 abnormality of cartilage of external ear 59 Frequent (79-30%)
34 narrow palpebral fissure 59 Frequent (79-30%)
35 broad hallux 32 HP:0010055
36 postaxial polydactyly 32 HP:0100259
37 heterotaxy 59 Occasional (29-5%)
38 complete atrioventricular canal defect 32 HP:0001674

Clinical features from OMIM:

217095

MGI Mouse Phenotypes related to Conotruncal Heart Malformations:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.02 GATA6 GDF1 NKX2-5 NKX2-6 PLXND1 TBX1
2 cellular MP:0005384 10 GATA6 GDF1 NKX2-5 NKX2-6 PLXND1 TBX1
3 embryo MP:0005380 9.88 GATA6 GDF1 NKX2-5 NKX2-6 PLXND1 TBX1
4 growth/size/body region MP:0005378 9.8 GATA6 GDF1 NKX2-5 NKX2-6 PLXND1 TBX1
5 mortality/aging MP:0010768 9.8 GATA6 GDF1 NKX2-5 NKX2-6 PLXND1 TBX1
6 endocrine/exocrine gland MP:0005379 9.77 GDF1 NKX2-5 PLXND1 TBX1 ZFPM2
7 craniofacial MP:0005382 9.73 GDF1 NKX2-5 PLXND1 TBX1
8 muscle MP:0005369 9.55 GATA6 NKX2-5 PLXND1 TBX1 ZFPM2
9 normal MP:0002873 9.5 GATA6 GDF1 NKX2-5 NKX2-6 PLXND1 TBX1
10 respiratory system MP:0005388 9.1 GATA6 GDF1 NKX2-5 NKX2-6 TBX1 ZFPM2

Drugs & Therapeutics for Conotruncal Heart Malformations

Drugs for Conotruncal Heart Malformations (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 38)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Simendan Investigational Phase 3 131741-08-7
2 Cardiotonic Agents Phase 3
3 Protective Agents Phase 3
4 Phosphodiesterase Inhibitors Phase 3
5 Vasodilator Agents Phase 3
6 Phosphodiesterase 3 Inhibitors Phase 3
7
Pembrolizumab Approved Phase 1, Phase 2 1374853-91-4
8
Nintedanib Approved Phase 2 656247-17-5 56843413
9
Capecitabine Approved, Investigational Phase 2 154361-50-9 60953
10
Tyrosine Approved, Investigational, Nutraceutical Phase 2 60-18-4 6057
11 Antineoplastic Agents, Immunological Phase 1, Phase 2
12 Antimetabolites Phase 2
13 Antimetabolites, Antineoplastic Phase 2
14 Mitogens Phase 1
15 Interleukin-12 Phase 1
16
Methylcobalamin Approved, Experimental, Investigational 13422-55-4
17
leucovorin Approved 58-05-9 143 6006
18
Hydroxocobalamin Approved 13422-51-0 11953898 15589840
19
Parathyroid hormone Approved, Investigational 9002-64-6
20
Sodium citrate Approved, Investigational 68-04-2
21
Folic acid Approved, Nutraceutical, Vet_approved 59-30-3 6037
22
Cyanocobalamin Approved, Nutraceutical 68-19-9 44176380
23
Citric acid Approved, Nutraceutical, Vet_approved 77-92-9 311
24
Calcium Approved, Nutraceutical 7440-70-2 271
25
Cobalamin Experimental 13408-78-1 6857388
26 Folate
27 Vitamin B9
28 Vitamin B 12
29 Vitamin B Complex
30 Vitamin B12
31 Citrate
32 Hormones
33 Chelating Agents
34 Anticoagulants
35 Calcium, Dietary
36 Bone Density Conservation Agents
37 Nutrients
38 Liver Extracts

Interventional clinical trials:

(show all 29)
# Name Status NCT ID Phase Drugs
1 Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS Recruiting NCT03505021 Phase 3 Levosimendan;Placebo for levosimendan
2 A Phase I/IIA Study to Assess Safety, Tolerability and Preliminary Activity of the Combination of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Patients With Advanced Solid Malignancies (FAK-PD1) Recruiting NCT02758587 Phase 1, Phase 2 Defactinib;Pembrolizumab
3 A Phase I/II Study of Nintedanib and Capecitabine in Refractory Metastatic Colorectal Cancer Active, not recruiting NCT02393755 Phase 2 Capecitabine;Nintedanib
4 A Phase 1 Cohort Dose-Escalation Trial of AVID200, a Transforming Growth Factor β (TGFβ) Inhibitor, in Patients With Advanced or Metastatic Solid Tumor Malignancies Recruiting NCT03834662 Phase 1 AVID200
5 Clinical Trial Study of Interventional Therapy Sequential With the Fourth-generation CAR-T Cells (IL7 and CCL19 or / and IL12) Targeting Nectin4/FAP in the Treatment of Advanced Malignant Solid Tumors With Nectin4-positive Recruiting NCT03932565 Phase 1
6 Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome Unknown status NCT00005102
7 Incision Type for Lateral Internal Sphincterotomy Unknown status NCT00980369
8 Genes Causing Congenital Ebstein's Anomaly Completed NCT00497705
9 Pulmonic SAPIEN XT™ THV A Multi-center, Observational Registry With Retrospective Enrollment of Patients That Underwent Transcatheter Pulmonic Valve Implantation and a Retrospective or Prospective Follow-up Completed NCT02302131
10 Transcatheter Valve Implantation in Patients With Dysfunctional Left and Right Sided Heart Valves Completed NCT02119442
11 Conotruncal Cardiac Defects and Metabolism, Nutrigenetic Factors of Etiopathogeny of Conotruncal Cardiac Defects Completed NCT01460316
12 TEE-guided Perventricular Device Closure Through Minithoracotomy vs Traditional Surgery Repair Via CBP in Treatment of Infundibular Ventricular Septal Defect:A Two-center Clinical Randomized Controlled Trial Completed NCT02361008
13 Computer Modeling of Congenital Heart Disease Completed NCT00366847
14 Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac Defects Completed NCT00004361 calcium gluconate;sodium citrate
15 Gene and Nutrient Etiologies of Human Heart Defects Completed NCT00368732
16 Family Study of Congenital Cardiovascular Malformations Completed NCT00005258
17 Kaohsiung Medical University Chung-Ho Memorial Hospital Completed NCT02587793
18 The Impact of Lung Cancer-derived Fibroblasts on Mast Cells Activation Completed NCT02161523
19 Congenital Heart Disease (CHD): Hemodynamic Effects of Acute Maternal Hyperoxygenation in the Fetus Recruiting NCT03944837
20 Surgical Planning for Reconstruction of Complex Heart Defects Recruiting NCT00972608
21 COngenital Multicenter Trial of Pulmonic vAlve Dysfunction Studying the SAPIEN 3 interventIONal THV Recruiting NCT02744677
22 Role of the Peritoneal Microenvironment in the Pathogenesis and Spread of Colorectal Carcinomatosis Recruiting NCT03777943
23 Management of Prenatally Diagnosed Isolated Right Aortic Arch: the ARCADE Study Recruiting NCT04029064
24 Monitor Faecal Calprotectin Concentration in Infants With Heart Defects Recruiting NCT03255564
25 Pulmonic SAPIEN S3™ THV Registry A Multi-center, Observational Registry With Retrospective Enrollment of Patients That Underwent Transcatheter Pulmonic Valve Implantation and a Retrospective or Prospective Follow-up Active, not recruiting NCT02777892
26 Prospective, Non-randomised, Open Label Clinical Study to Assess the Safety of the Bioabsorbable Pulmonary Valved Conduit (PV-001) in Subjects Undergoing Right Ventricular Outflow Tract (RVOT) Reconstruction Active, not recruiting NCT02700100
27 Adult Pulmonary Valve Replacement: A Simple and Reproducible Technique Terminated NCT00384163
28 Percutaneous Interventions in Adults With Complex Cyanotic Congenital Heart Disease Terminated NCT00266916
29 A Review of the Diagnosis, Treatment and Outcomes of Children With Critical Congenital Heart Defects Terminated NCT00208689

Search NIH Clinical Center for Conotruncal Heart Malformations

Cochrane evidence based reviews: truncus arteriosus, persistent

Genetic Tests for Conotruncal Heart Malformations

Genetic tests related to Conotruncal Heart Malformations:

# Genetic test Affiliating Genes
1 Conotruncal Heart Malformations 29 GATA6 NKX2-5 NKX2-6 TBX1
2 Truncus Arteriosus 29
3 Truncus Arteriosus Communis 29

Anatomical Context for Conotruncal Heart Malformations

MalaCards organs/tissues related to Conotruncal Heart Malformations:

41
Heart, Thymus, Liver, Lung, Bone, T Cells, Smooth Muscle
LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Conotruncal Heart Malformations:
# Tissue Anatomical CompartmentCell Relevance
1 Heart Aorticopulmonary Septum Affected by disease
2 Heart Outflow Tract Cushion Affected by disease
3 Neural Crest Cardiac Neural Crest Cardiac Neural Crest Cells Affected by disease, potential therapeutic candidate
4 Head Mesenchyme Branchial Arch 3,4,6 Cardiac Neural Crest Cells Affected by disease, potential therapeutic candidate
5 Heart Outflow Tract Neural Crest Outflow Tract Cells Affected by disease, potential therapeutic candidate

Publications for Conotruncal Heart Malformations

Articles related to Conotruncal Heart Malformations:

(show top 50) (show all 390)
# Title Authors PMID Year
1
GATA6 mutations cause human cardiac outflow tract defects by disrupting semaphorin-plexin signaling. 38 8 71
19666519 2009
2
Common arterial trunk associated with a homeodomain mutation of NKX2.6. 38 8 71
15649947 2005
3
Conotruncal malformations and absent thymus due to a deleterious NKX2-6 mutation. 8 71
24421281 2014
4
Novel ZFPM2/FOG2 variants in patients with double outlet right ventricle. 8 71
21919901 2012
5
New mutations in ZFPM2/FOG2 gene in tetralogy of Fallot and double outlet right ventricle. 8 71
20807224 2011
6
NKX2.5 mutations in patients with congenital heart disease. 8 71
14607454 2003
7
A single major-gene defect underlying cardiac conotruncal malformations interferes with myocardial growth during embryonic development: studies in the CTD line of keeshond dogs. 38 8
8430699 1993
8
Prevalence and penetrance of ZFPM2 mutations and deletions causing congenital diaphragmatic hernia. 71
24702427 2015
9
Isolated truncus arteriosus associated with a mutation in the plexin-D1 gene. 8
24254849 2013
10
Mutational spectrum in the cardiac transcription factor gene NKX2.5 (CSX) associated with congenital heart disease. 71
20456451 2010
11
Comprehensive genotype-phenotype analysis in 230 patients with tetralogy of Fallot. 71
19948535 2010
12
Loss-of-function mutations in growth differentiation factor-1 (GDF1) are associated with congenital heart defects in humans. 71
17924340 2007
13
Candidate genes for congenital diaphragmatic hernia from animal models: sequencing of FOG2 and PDGFRalpha reveals rare variants in diaphragmatic hernia patients. 71
17568391 2007
14
Missense mutation in the transcription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis. 71
16418214 2006
15
Mutations of ZFPM2/FOG2 gene in sporadic cases of tetralogy of Fallot. 71
14517948 2003
16
Role of TBX1 in human del22q11.2 syndrome. 8
14585638 2003
17
NKX2.5 mutations in patients with tetralogy of fallot. 71
11714651 2001
18
Loss of function and inhibitory effects of human CSX/NKX2.5 homeoprotein mutations associated with congenital heart disease. 71
10903346 2000
19
Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. 71
10587520 1999
20
A 22q11.2 deletion that excludes UFD1L and CDC45L in a patient with conotruncal and craniofacial defects. 8
10417299 1999
21
Molecular and clinical study of 183 patients with conotruncal anomaly face syndrome. 8
9737780 1998
22
The incidence of a deletion in chromosome 22Q11 in sporadic and familial conotruncal heart disease. 8
8839734 1996
23
Familial non-syndromic conotruncal defects are not associated with a 22q11 microdeletion. 8
8566942 1996
24
Frequency of a 22q11 deletion in patients with conotruncal cardiac malformations: a prospective study. 8
8582397 1995
25
Confirmation that the conotruncal anomaly face syndrome is associated with a deletion within 22q11.2. 8
7856665 1994
26
Genetics of conotruncal malformations: further evidence of autosomal recessive inheritance. 8
8042678 1994
27
Genetics of conotruncal malformations: review of the literature and report of a consanguineous kindred with various conotruncal malformations. 8
2194395 1990
28
[Truncus arteriosus: an autosomal recessive disease?]. 8
2625625 1989
29
Cardiac malformations in relatives of children with truncus arteriosus or interruption of the aortic arch. 8
3341225 1988
30
GATA6 mutations: Characterization of two novel patients and a comprehensive overview of the GATA6 genotypic and phenotypic spectrum. 38
31301121 2019
31
Successful Truncal Valve Replacement After Truncal Valve Repairs. 38
31152185 2019
32
Partially Penetrant Cardiac Neural Crest Defects in Hand1 Phosphomutant Mice: Dimer Choice That Is Not So Critical. 38
31338559 2019
33
Gata4 regulates hedgehog signaling and Gata6 expression for outflow tract development. 38
31120883 2019
34
Challenges with Managing Delayed Presentation of Persistent Truncus Arteriosus with Torrential Pulmonary Blood Flow in a Resource-Limited Setting. 38
31392125 2019
35
Persistent truncus arteriosus with absent semilunar valve in first trimester. 38
30637595 2019
36
Anomalous origin of left vertebral artery from ascending aorta associated with interrupted aortic arch and persistent truncus arteriosus. 38
30714544 2019
37
Foxc2 is required for proper cardiac neural crest cell migration, outflow tract septation, and ventricle expansion. 38
30376688 2018
38
Dysregulation of TBX1 dosage in the anterior heart field results in congenital heart disease resembling the 22q11.2 duplication syndrome. 38
29509905 2018
39
Outcomes of Right Ventricular Outflow Tract Reconstruction for Children with Persistent Truncus Arteriosus: A 10-Year Single-Center Experience. 38
29255914 2018
40
Mutations in Hnrnpa1 cause congenital heart defects. 38
29367466 2018
41
Targeted sequencing identifies novel GATA6 variants in a large cohort of patients with conotruncal heart defects. 38
29101065 2018
42
Cardio-cephalic neural crest syndrome: A novel hypothesis of vascular neurocristopathy. 38
28814167 2017
43
Landmark lecture: Perloff lecture: Tribute to Professor Joseph Kayle Perloff and lessons learned from him: aortopathy in adults with CHD. 38
29286269 2017
44
An unusual and rare form of truncus arteriosus in an asymptomatic woman. 38
29163663 2017
45
Cardiac Truncus Arteriosus in an Eastern Black Rhinoceros (Diceros bicornis michaeli). 38
29169622 2017
46
The Burden of Truncus Arteriosus in an Urban City in Africa: How are we Fairing? 38
29326774 2017
47
Pdgfrα functions in endothelial-derived cells to regulate neural crest cells and the development of the great arteries. 38
28714851 2017
48
Reduced dosage of β-catenin provides significant rescue of cardiac outflow tract anomalies in a Tbx1 conditional null mouse model of 22q11.2 deletion syndrome. 38
28346476 2017
49
Do toxic metals and trace elements have a role in the pathogenesis of conotruncal heart malformations? 38
27751200 2017
50
TBX20 loss-of-function mutation responsible for familial tetralogy of Fallot or sporadic persistent truncus arteriosus. 38
28553164 2017

Variations for Conotruncal Heart Malformations

ClinVar genetic disease variations for Conotruncal Heart Malformations:

6 (show all 33)
# Gene Variation Type Significance SNP ID GRCh37 Pos GRCh38 Pos
1 NKX2-6 NM_001136271.2(NKX2-6): c.451T> C (p.Phe151Leu) single nucleotide variant Pathogenic rs267606914 8:23560419-23560419 8:23702906-23702906
2 GATA6 GATA6, 2-BP DEL, 1456GA deletion Pathogenic
3 GATA6 NM_005257.5(GATA6): c.1396A> C (p.Asn466His) single nucleotide variant Pathogenic rs387906813 18:19761507-19761507 18:22181546-22181546
4 ZFPM2 NM_012082.4(ZFPM2): c.681T> G (p.Ile227Met) single nucleotide variant Pathogenic rs397514520 8:106801094-106801094 8:105788866-105788866
5 ZFPM2 NM_012082.4(ZFPM2): c.2209A> G (p.Lys737Glu) single nucleotide variant Pathogenic rs397514521 8:106814519-106814519 8:105802291-105802291
6 NKX2-6 NM_001136271.2(NKX2-6): c.453_454insT (p.Lys152Ter) insertion Pathogenic rs587777422 8:23560416-23560417 8:23702903-23702904
7 ZFPM2 NM_012082.4(ZFPM2): c.2107A> C (p.Met703Leu) single nucleotide variant Pathogenic rs121908603 8:106814417-106814417 8:105802189-105802189
8 GDF1 NM_001492.6(GDF1): c.800G> A (p.Cys267Tyr) single nucleotide variant Pathogenic rs121434423 19:18979725-18979725 19:18868916-18868916
9 NKX2-5 NM_004387.4(NKX2-5): c.73C> T (p.Arg25Cys) single nucleotide variant Conflicting interpretations of pathogenicity rs28936670 5:172662014-172662014 5:173235011-173235011
10 NKX2-6 NM_001136271.2(NKX2-6): c.464G> T (p.Arg155Leu) single nucleotide variant Uncertain significance 8:23560406-23560406 8:23702893-23702893
11 NKX2-6 NM_001136271.2(NKX2-6): c.686C> T (p.Ala229Val) single nucleotide variant Uncertain significance 8:23560184-23560184 8:23702671-23702671
12 TBX1 NM_080647.1(TBX1): c.324C> T (p.Ala108=) single nucleotide variant Uncertain significance 22:19748717-19748717 22:19761194-19761194
13 NKX2-6 NM_001136271.2(NKX2-6): c.895A> G (p.Arg299Gly) single nucleotide variant Uncertain significance 8:23559975-23559975 8:23702462-23702462
14 GATA6 NM_005257.5(GATA6): c.233T> C (p.Leu78Pro) single nucleotide variant Uncertain significance rs1253034411 18:19751338-19751338 18:22171377-22171377
15 GATA6 NM_005257.5(GATA6): c.839G> C (p.Gly280Ala) single nucleotide variant Uncertain significance rs904519303 18:19751944-19751944 18:22171983-22171983
16 TBX1 NM_080647.1(TBX1): c.1049G> A (p.Gly350Asp) single nucleotide variant Uncertain significance rs781731042 22:19753951-19753951 22:19766428-19766428
17 MYCN NM_005378.6(MYCN): c.1226C> T (p.Pro409Leu) single nucleotide variant Uncertain significance rs1553371013 2:16086050-16086050 2:15945928-15945928
18 NKX2-6 NM_001136271.2(NKX2-6): c.826G> T (p.Ala276Ser) single nucleotide variant Uncertain significance rs959054178 8:23560044-23560044 8:23702531-23702531
19 NKX2-6 NM_001136271.2(NKX2-6): c.745G> A (p.Gly249Arg) single nucleotide variant Uncertain significance rs752427485 8:23560125-23560125 8:23702612-23702612
20 NKX2-5 NM_004387.4(NKX2-5): c.865_867AAC[2] (p.Asn291del) short repeat Uncertain significance rs756974215 5:172659674-172659676 5:173232671-173232673
21 NKX2-6 NM_001136271.2(NKX2-6): c.274C> A (p.Gln92Lys) single nucleotide variant Uncertain significance rs530501230 8:23563838-23563838 8:23706325-23706325
22 NKX2-6 NM_001136271.2(NKX2-6): c.340_348dup (p.Asn114_Gly116dup) duplication Uncertain significance rs780012501 8:23560522-23560530 8:23703009-23703017
23 NKX2-6 NM_001136271.2(NKX2-6): c.121T> A (p.Phe41Ile) single nucleotide variant Uncertain significance rs576577900 8:23563991-23563991 8:23706478-23706478
24 NKX2-6 NM_001136271.2(NKX2-6): c.29C> G (p.Pro10Arg) single nucleotide variant Likely benign rs747477274 8:23564083-23564083 8:23706570-23706570
25 NKX2-6 NM_001136271.2(NKX2-6): c.359G> C (p.Arg120Pro) single nucleotide variant Likely benign rs61743032 8:23560511-23560511 8:23702998-23702998
26 NKX2-6 NM_001136271.2(NKX2-6): c.276G> A (p.Gln92=) single nucleotide variant Likely benign rs768775204 8:23560594-23560594 8:23703081-23703081
27 NKX2-6 NM_001136271.2(NKX2-6): c.867C> T (p.Gly289=) single nucleotide variant Likely benign rs1554510734 8:23560003-23560003 8:23702490-23702490
28 ZFPM2 NM_012082.4(ZFPM2): c.89A> G (p.Glu30Gly) single nucleotide variant Likely benign rs121908601 8:106431420-106431420 8:105419192-105419192
29 NKX2-6 NM_001136271.2(NKX2-6): c.180C> T (p.Gly60=) single nucleotide variant Likely benign rs1356335573 8:23563932-23563932 8:23706419-23706419
30 GATA6 NM_005257.5(GATA6): c.969_971CCA[9] (p.His333del) short repeat Benign rs562588574 18:19752073-19752075 18:22172112-22172114
31 NKX2-6 NM_001136271.2(NKX2-6): c.786C> G (p.Gly262=) single nucleotide variant Benign rs61749320 8:23560084-23560084 8:23702571-23702571
32 NKX2-6 NM_001136271.2(NKX2-6): c.386C> A (p.Ala129Glu) single nucleotide variant Benign rs143039156 8:23560484-23560484 8:23702971-23702971
33 NKX2-6 NM_001136271.2(NKX2-6): c.183C> T (p.Gly61=) single nucleotide variant Benign rs139466287 8:23563929-23563929 8:23706416-23706416

UniProtKB/Swiss-Prot genetic disease variations for Conotruncal Heart Malformations:

74
# Symbol AA change Variation ID SNP ID
1 GATA6 p.Asn466His VAR_067388 rs387906813
2 GDF1 p.Cys267Tyr VAR_065335 rs121434423
3 NKX2-6 p.Phe151Leu VAR_063278 rs267606914
4 NKX2-6 p.Lys152Gln VAR_073164
5 NKX2-6 p.Val176Ala VAR_073165
6 TBX1 p.Phe148Tyr VAR_035025 rs28939675
7 ZFPM2 p.Glu30Gly VAR_017942 rs121908601
8 ZFPM2 p.Ile227Val VAR_072074 rs202204708

Expression for Conotruncal Heart Malformations

Search GEO for disease gene expression data for Conotruncal Heart Malformations.

Pathways for Conotruncal Heart Malformations

Pathways related to Conotruncal Heart Malformations according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.46 TBX1 NKX2-5 GATA6

GO Terms for Conotruncal Heart Malformations

Biological processes related to Conotruncal Heart Malformations according to GeneCards Suite gene sharing:

(show all 22)
# Name GO ID Score Top Affiliating Genes
1 multicellular organism development GO:0007275 9.89 TBX1 PLXND1 NKX2-6 NKX2-5
2 positive regulation of transcription by RNA polymerase II GO:0045944 9.88 ZFPM2 TBX1 NKX2-6 NKX2-5 GATA6
3 positive regulation of transcription, DNA-templated GO:0045893 9.81 ZFPM2 TBX1 NKX2-5 GATA6
4 BMP signaling pathway GO:0030509 9.61 NKX2-5 GDF1
5 epithelial cell differentiation GO:0030855 9.6 TBX1 GATA6
6 vasculogenesis GO:0001570 9.58 ZFPM2 NKX2-5
7 outflow tract morphogenesis GO:0003151 9.58 TBX1 PLXND1 NKX2-5
8 heart morphogenesis GO:0003007 9.57 TBX1 NKX2-5
9 ventricular septum morphogenesis GO:0060412 9.56 ZFPM2 NKX2-5
10 positive regulation of cardiac muscle cell proliferation GO:0060045 9.55 ZFPM2 GATA6
11 thyroid gland development GO:0030878 9.54 TBX1 NKX2-5
12 cardiac muscle cell differentiation GO:0055007 9.52 NKX2-5 GATA6
13 embryonic heart tube development GO:0035050 9.49 NKX2-6 NKX2-5
14 ventricular cardiac muscle cell development GO:0055015 9.46 NKX2-6 NKX2-5
15 positive regulation of cardioblast differentiation GO:0051891 9.43 NKX2-5 GATA6
16 pharyngeal system development GO:0060037 9.43 TBX1 NKX2-6 NKX2-5
17 atrial cardiac muscle cell development GO:0055014 9.37 NKX2-6 NKX2-5
18 cardiac muscle tissue development GO:0048738 9.33 ZFPM2 NKX2-5 GATA6
19 right ventricular cardiac muscle tissue morphogenesis GO:0003221 9.32 ZFPM2 NKX2-5
20 cell development GO:0048468 9.27 GDF1
21 heart development GO:0007507 9.26 ZFPM2 TBX1 NKX2-6 NKX2-5
22 outflow tract septum morphogenesis GO:0003148 8.92 ZFPM2 TBX1 NKX2-5 GATA6

Molecular functions related to Conotruncal Heart Malformations according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 DNA binding GO:0003677 9.72 ZFPM2 TBX1 NKX2-6 NKX2-5 GATA6
2 DNA-binding transcription factor activity GO:0003700 9.46 TBX1 NKX2-6 NKX2-5 GATA6
3 transcription factor binding GO:0008134 9.43 ZFPM2 NKX2-5 GATA6
4 DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981 9.35 ZFPM2 TBX1 NKX2-6 NKX2-5 GATA6
5 sequence-specific DNA binding GO:0043565 8.92 TBX1 NKX2-6 NKX2-5 GATA6

Sources for Conotruncal Heart Malformations

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....